SITC Summit on Intralesional Immunotherapy: Moving Beyond Oncolytic Viruses

Thursday, Sept. 19, 2024 - 11 a.m.–3:15 p.m. EDT

This open-door virtual event will present the current state and future directions of the field and feature participation of invited stakeholders involved in intralesional immunotherapy research and development.

A Deep Dive into CD3 Engagers in Solid Tumors and TCR by CD3 in Solid Tumors Live Webinar

Wednesday, Sept. 25, 2024 - 12–2 p.m. EDT

This webinar will address current studies to safer CD3-targeting immunotherapies that maintain clinical efficacy in the immunosuppressive TME while minimizing cytokine release and other toxicities.

Predicting Drug Resistance and Drug Repurposing with Imaging-Based AI: AI in IO Webinar 

Wednesday, Sept. 25, 2024 - 1:30 p.m.–2:30 p.m. EDT

Advance your training in computational immuno-oncology! This webinar will discuss specific applications of imaging-based AI to give a better understanding of immuno-therapeutic mechanisms.

SITC Immuno-oncology Drug Development Summit

Sept. 30 – Oct. 1, 2024 in Boston at The Revere Hotel Boston Common

The SITC Immuno-oncology Drug Development Summit will ensure that active, innovative new therapies are rapidly and appropriately moved into clinical testing.

Advances in Cancer Immunotherapy™ (ACI) Series

ACI programs are certified for CME, CNE, CPE, and MOC credits. ACI's offer in-depth clinical training in immunotherapy treatment for a variety of disease states and topics. ACI webinars are FREE for healthcare professionals, students, patients and patient advocates.

Advances in Cancer Immunotherapy™: A Focus on Radiation Oncology

Sunday, Sept. 29 |2:30–4:30 p.m. ET 
Live at ASTRO 2024

Gain an understanding of the current status of knowledge of the mechanisms of action of combinations of immunotherapeutic agents and radiation that can inform treatment decisions.

Primer on Radiation Therapy-Induced Modulation of the TME

Thursday, Oct. 3 | 10:30 a.m.–12:30 p.m. ET | Live at ImmunoRad 2024

Understand novel strategies to address checkpoint resistance with the SITC and Weill Cornell Medicine Primer on Radiation Therapy-Induced Modulation of the TME. 

Advances in Cancer Immunotherapy™: A Focus on Intratumoral Therapies, Vaccines, & Cytokines

Wednesday, Oct. 9 |11 a.m.–3 p.m. ET Virtual – Zoom

Program features a session on emerging therapies, where the EMERALD trial and FLASH radiotherapy plan to be discussed. 

Advances in Cancer Immunotherapy™: A Focus on Pathology

Tuesday, Dec. 10 |11 a.m.–3 p.m. ET Virtual – Zoom

Join SITC and a panel of experts for an afternoon of in-depth education on all aspects of the clinical implementation of immuno-oncology pathology.

2025 Cancer Immunotherapy Winter School

February 11–14, 2025 in Austin, TX
and Virtually

Explore the core principles of tumor immunology and cancer immunotherapy, including biomarker technology, validation and clinical integration, clinical trial design, data analysis and considerations for combination therapies.

2025 Spring Scientific: Cellular Therapy for Solid Tumors

March 12–14, 2025 in San Diego, CA
& Virtually

SITC will bring the brightest minds and the next generation of leaders together to explore promising science and develop novel opportunities to challenges that impede bringing these novel therapies to patients in need.